Monoacylglycerol lipase contributes to pathogenesis of Alzheimer's disease

Monoacylglycerol lipase contributes to pathogenesis of Alzheimer's disease

Alzheimer’s disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglycerol...

Full description

Bibliographic Details
Main Authors: Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Chen, Chu
Other Authors: Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Format: Article
Published: Elsevier 2017
Online Access:http://hdl.handle.net/1721.1/112276
https://orcid.org/0000-0002-8021-277X

Internet

http://hdl.handle.net/1721.1/112276
https://orcid.org/0000-0002-8021-277X

Similar Items